Biomaterials

Edit Your Profile

Biomaterials Journal

publication venue for

Inhibition of glycolysis in the presence of antigen generates suppressive antigen-specific responses and restrains rheumatoid arthritis in mice. 277. 2021
Discovery of synergistic material-topography combinations to achieve immunomodulatory osteoinductive biomaterials using a novel in vitro screening method: The ChemoTopoChip. 271. 2021
Safe scarless cassette-free selection of genome-edited human pluripotent stem cells using temporary drug resistance. 262. 2020
A designer bow-tie combination therapeutic platform: An approach to resistant cancer treatment by simultaneous delivery of cytotoxic and anti-inflammatory agents and radiation. 187:117-129. 2018
Biological safety and tissue distribution of (16-mercaptohexadecyl) trimethylammonium bromide-modified cationic gold nanorods. 154:275-290. 2018
Nutrient-deprived cancer cells preferentially use sialic acid to maintain cell surface glycosylation. 70:23-36. 2015
In vivo multimodal magnetic particle imaging (MPI) with tailored magneto/optical contrast agents. 52:251-261. 2015
A microwell pattern for C17.2 cell aggregate formation with concave cylindrical surface induced cell peeling. 35:9423-9437. 2014
The effect of systemic PTEN antagonist peptides on axon growth and functional recovery after spinal cord injury. 35:4610-4626. 2014
Transport and biodistribution of dendrimers across human fetal membranes: Implications for intravaginal administration of dendrimer-drug conjugates. 31:5007-5021. 2010
The role of organ level conditioning on the promotion of engineered heart valve tissue development in-vitro using mesenchymal stem cells. 31:1114-1125. 2010
Plasma-sprayed carbon nanotube reinforced hydroxyapatite coatings and their interaction with human osteoblasts in vitro. 28:618-624. 2007
Mechanical characterization of collagen fibers and scaffolds for tissue engineering. 24:3805-3813. 2003
Biointeractive polymers and tissue engineered blood vessels. 17:329-336. 1996
Functional delivery of DNAzyme with iron oxide nanoparticles for hepatitis C virus gene knockdown. 2012

International Standard Serial Number (ISSN)

0142-9612

Electronic International Standard Serial Number (EISSN)

1878-5905